Gut–Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers

Martina Lombardi,Jacopo Troisi,Benedetta Maria Motta,Pietro Torre,Mario Masarone,Marcello Persico

DOI: https://doi.org/10.3390/nu16071025

IF: 5.9

2024-04-02

Nutrients

Abstract:Portal hypertension (PH) is a complex clinical challenge with severe complications, including variceal bleeding, ascites, hepatic encephalopathy, and hepatorenal syndrome. The gut microbiota (GM) and its interconnectedness with human health have emerged as a captivating field of research. This review explores the intricate connections between the gut and the liver, aiming to elucidate how alterations in GM, intestinal barrier function, and gut-derived molecules impact the development and progression of PH. A systematic literature search, following PRISMA guidelines, identified 12 original articles that suggest a relationship between GM, the gut–liver axis, and PH. Mechanisms such as dysbiosis, bacterial translocation, altered microbial structure, and inflammation appear to orchestrate this relationship. One notable study highlights the pivotal role of the farnesoid X receptor axis in regulating the interplay between the gut and liver and proposes it as a promising therapeutic target. Fecal transplantation experiments further emphasize the pathogenic significance of the GM in modulating liver maladies, including PH. Recent advancements in metagenomics and metabolomics have expanded our understanding of the GM's role in human ailments. The review suggests that addressing the unmet need of identifying gut–liver axis-related metabolic and molecular pathways holds potential for elucidating pathogenesis and directing novel therapeutic interventions.

nutrition & dietetics

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of gut microbiota (GM) and its interaction with human health in the occurrence and development of portal hypertension (PH). Specifically, the paper aims to clarify how changes in gut microbiota, intestinal barrier dysfunction, and molecules from the gut affect the development and progression of PH. Through a systematic review of the literature, the paper identified 12 original articles, which revealed the relationships among gut microbiota, gut - liver axis (GLA), and portal hypertension. The paper also discussed how mechanisms such as dysbiosis, bacterial translocation, changes in microbial structure, and inflammation coordinate this relationship, and emphasized the crucial role of the farnesol X - receptor axis in regulating the interaction between the gut and the liver, and proposed its potential as a treatment target.

The objectives of the paper are:
1. **Clarify the complex connection between gut microbiota and portal hypertension**: Provide a comprehensive overview of current knowledge by analyzing existing literature evidence.
2. **Identify research gaps**: Point out areas that require further research and discovery.
3. **Emphasize clinical relevance**: Emphasize the potential significance of understanding gut microbiota - mediated perturbations in the management of portal hypertension, especially in patient stratification and disease management.

Through these objectives, the paper hopes to provide new perspectives and methods for the early detection of portal hypertension, the elucidation of disease progression mechanisms, and precise treatment interventions.